IDH1 and glioma: Mutations to IDH1/2 are important events in several types of cancers, including acute myeloid leukemia (AML), glioma, angio-immunoblastic T-cell lymphoma, chondrosarcoma, intrahepatic cholangiocarcinoma, and so on (8–11).